Prostate-Specific Antigen
"Prostate-Specific Antigen" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A glycoprotein that is a kallikrein-like serine proteinase and an esterase, produced by epithelial cells of both normal and malignant prostate tissue. It is an important marker for the diagnosis of prostate cancer.
| Descriptor ID |
D017430
|
| MeSH Number(s) |
D08.811.277.656.300.760.442.750 D08.811.277.656.959.350.442.750 D12.776.866.249.500 D23.050.285.625 D23.101.140.625
|
| Concept/Terms |
Prostate-Specific Antigen- Prostate-Specific Antigen
- gamma-Seminoprotein
- gamma Seminoprotein
- Prostate Specific Antigen
- hK3 Kallikrein
- Kallikrein, hK3
- Semenogelase
- Kallikrein hK3
- Seminin
|
Below are MeSH descriptors whose meaning is more general than "Prostate-Specific Antigen".
Below are MeSH descriptors whose meaning is more specific than "Prostate-Specific Antigen".
This graph shows the total number of publications written about "Prostate-Specific Antigen" by people in this website by year, and whether "Prostate-Specific Antigen" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 3 | 2 | 5 |
| 1996 | 2 | 2 | 4 |
| 1997 | 0 | 3 | 3 |
| 1998 | 1 | 3 | 4 |
| 1999 | 1 | 1 | 2 |
| 2000 | 6 | 1 | 7 |
| 2001 | 2 | 2 | 4 |
| 2002 | 2 | 2 | 4 |
| 2003 | 1 | 12 | 13 |
| 2004 | 6 | 5 | 11 |
| 2005 | 1 | 7 | 8 |
| 2006 | 3 | 5 | 8 |
| 2007 | 1 | 9 | 10 |
| 2008 | 2 | 8 | 10 |
| 2009 | 4 | 2 | 6 |
| 2010 | 1 | 5 | 6 |
| 2011 | 4 | 10 | 14 |
| 2012 | 3 | 2 | 5 |
| 2013 | 5 | 5 | 10 |
| 2014 | 1 | 4 | 5 |
| 2015 | 4 | 7 | 11 |
| 2016 | 2 | 3 | 5 |
| 2017 | 0 | 4 | 4 |
| 2018 | 1 | 5 | 6 |
| 2019 | 2 | 3 | 5 |
| 2020 | 0 | 1 | 1 |
| 2021 | 1 | 3 | 4 |
| 2022 | 0 | 3 | 3 |
| 2023 | 0 | 3 | 3 |
| 2024 | 3 | 1 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prostate-Specific Antigen" by people in Profiles.
-
Irreversible electroporation for prostate cancer: another promising focal therapy. Einstein (Sao Paulo). 2024; 22:eRC0779.
-
Posttreatment surveillance intensity and overall survival in prostate cancer survivors (AFT-30). JNCI Cancer Spectr. 2024 Nov 01; 8(6).
-
Circulating Tumor Cell Count and Overall Survival in Patients With Metastatic Hormone-Sensitive Prostate Cancer. JAMA Netw Open. 2024 Oct 01; 7(10):e2437871.
-
Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious CDK12 Alterations in the Phase 2 IMPACT Trial. Clin Cancer Res. 2024 Aug 01; 30(15):3200-3210.
-
ProsTAV, a clinically useful test in prostate cancer: an extension study. World J Urol. 2024 Jul 10; 42(1):395.
-
Epidemiology, treatment patterns, and clinical outcomes in de novo oligometastatic hormone-sensitive prostate cancer. Cancer. 2024 Nov 15; 130(22):3815-3825.
-
Development and Validation of an 18-Gene Urine Test for High-Grade Prostate Cancer. JAMA Oncol. 2024 Jun 01; 10(6):726-736.
-
Limited Evidence of Shared Decision Making for Prostate Cancer Screening in Audio-Recorded Primary Care Visits Among Black Men and their Healthcare Providers. J Immigr Minor Health. 2024 Oct; 26(5):866-877.
-
Noninferiority of Hypofractionated vs Conventional Postprostatectomy Radiotherapy for Genitourinary and Gastrointestinal Symptoms: The NRG-GU003 Phase 3 Randomized Clinical Trial. JAMA Oncol. 2024 May 01; 10(5):584-591.
-
Prostate Cancer Foundation Screening Guidelines for Black Men in the United States. NEJM Evid. 2024 May; 3(5):EVIDoa2300289.